Home › Companies › HAEMONETICS CORP. › 2024-2025

HAEMONETICS CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.

11Ballot items
349Asset managers
4,862Fund votes
July 25, 2024Meeting date

Results at a glance

Meeting of July 25, 2024: 11 items on HAEMONETICS CORP.’s Form 8-K, filed July 25, 2024: 2 approved · 9 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by HAEMONETICS CORP.

These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed July 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HAEMONETICS CORP. — official shareholder meeting results, meeting held July 25, 2024
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Christopher A. Simon	47,563,311	--	--	269,386	1,079,553	99.4%	Not verified	—
Elect Director: Robert E. Abernathy	47,233,098	--	--	599,599	1,079,553	99%	Not verified	—
Elect Director: Diane M. Bryant	47,637,507	--	--	195,190	1,079,553	99.5%	Not verified	—
Elect Director: Michael J. Coyle	47,492,931	--	--	339,766	1,079,553	99.2%	Not verified	—
Elect Director: Charles J. Dockendorff	46,789,643	--	--	1,043,054	1,079,553	98%	Not verified	—
Elect Director: Lloyd E. Johnson	47,243,880	--	--	588,817	1,079,553	99%	Not verified	—
Elect Director: Mark W. Kroll	46,938,807	--	--	893,890	1,079,553	98%	Not verified	—
Elect Director: Claire Pomeroy	47,553,094	--	--	279,603	1,079,553	99.4%	Not verified	—
Elect Director: Ellen M. Zane	47,122,780	--	--	709,917	1,079,553	99%	Not verified	—
2. The compensation of the Company's named executive officers based upon the following votes	46,230,466	1,460,004	142,227	--	1,079,553	97%	Approved	—
3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes	47,738,769	1,049,682	123,799	--	--	98%	Approved	—

Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on July 25, 2024 — read the filing on EDGAR.

How asset managers voted at the HAEMONETICS CORP. 2024-2025 meeting

Each item below shows how the 349 asset managers that disclosed a HAEMONETICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Charles J. Dockendorff

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 46,789,643WITHHELD: 1,043,054

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Charles J. Dockendorff

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 46,789,643 for, 1,043,054 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,289,880 for, 100,978 withheld.

FOR

FOR: 31,289,880WITHHOLD: 100,978

Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

2. Elect Director: Christopher A. Simon

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 47,563,311WITHHELD: 269,386

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Christopher A. Simon

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 47,563,311 for, 269,386 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,373,938 for, 16,920 withheld.

FOR

FOR: 31,373,938WITHHOLD: 16,920

Largest asset managers voting on “Election of Directors: Christopher A. Simon” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

3. Elect Director: Claire Pomeroy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 47,553,094WITHHELD: 279,603

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Claire Pomeroy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 47,553,094 for, 279,603 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 113 asset managers below reported 31,373,126 for, 17,732 withheld.

FOR

FOR: 31,373,126WITHHOLD: 17,732

Largest asset managers voting on “Election of Directors: Claire Pomeroy” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

4. Elect Director: Diane M. Bryant

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 47,637,507WITHHELD: 195,190

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Diane M. Bryant

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 47,637,507 for, 195,190 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,373,126 for, 17,732 withheld.

FOR

FOR: 31,373,126WITHHOLD: 17,732

Largest asset managers voting on “Election of Directors: Diane M. Bryant” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

5. Elect Director: Ellen M. Zane

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,122,780WITHHELD: 709,917

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Ellen M. Zane

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 47,122,780 for, 709,917 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,284,178 for, 102,252 withheld, 4,428 abstained.

FOR

FOR: 31,284,178ABSTAIN: 4,428WITHHOLD: 102,252

Largest asset managers voting on “Election of Directors: Ellen M. Zane” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

6. Elect Director: Lloyd E. Johnson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,243,880WITHHELD: 588,817

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Lloyd E. Johnson

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 47,243,880 for, 588,817 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 113 asset managers below reported 31,337,247 for, 49,183 withheld, 4,428 abstained.

FOR

FOR: 31,337,247ABSTAIN: 4,428WITHHOLD: 49,183

Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

7. Elect Director: Mark W. Kroll

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 46,938,807WITHHELD: 893,890

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Mark W. Kroll

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,938,807 for, 893,890 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 113 asset managers below reported 31,278,536 for, 112,322 withheld.

FOR

FOR: 31,278,536WITHHOLD: 112,322

Largest asset managers voting on “Election of Directors: Mark W. Kroll” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	130,753	66,859	Mixed
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

8. Elect Director: Michael J. Coyle

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 47,492,931WITHHELD: 339,766

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Michael J. Coyle

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 47,492,931 for, 339,766 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,373,938 for, 16,920 withheld.

FOR

FOR: 31,373,938WITHHOLD: 16,920

Largest asset managers voting on “Election of Directors: Michael J. Coyle” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

9. Elect Director: Robert E. Abernathy

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,233,098WITHHELD: 599,599

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: Election of Directors: Robert E. Abernathy

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 47,233,098 for, 599,599 withheld, per its Form 8-K filed July 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 113 asset managers below reported 31,311,343 for, 75,087 withheld, 4,428 abstained.

FOR

FOR: 31,311,343ABSTAIN: 4,428WITHHOLD: 75,087

Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

10. 2. The compensation of the Company's named executive officers based upon the following votes

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%

FOR: 46,230,466AGAINST: 1,460,004

Details: description as filed, official tally, votes by 340 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

HAEMONETICS CORP.’s own tally for this item (“2. The compensation of the Company's named executive officers based upon the following votes”): 46,230,466 for, 1,460,004 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 112 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Fund voting reports, all 112 managers: 31,224,330 for, 148,002 against, 16,920 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 262 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Against	Vote
Capital Research Global Investors	6,784,216	0	For
Neuberger Berman	3,712,042	0	For
Wellington	3,086,572	0	For
T. Rowe Price	2,105,208	0	For
State Street	1,680,593	52	For
BlackRock	1,578,887	6,441	For
FRANKLIN ADVISERS INC	1,271,175	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,137,440	0	For
Thrivent	813,550	0	For
SCHRODER INVESTMENT MANAGEMENT GROUP	733,017	0	For
Northern Trust	574,700	0	For
MELLON INVESTMENTS Corp	551,274	0	For
Charles Schwab	545,450	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	505,649	9,258	For
Allspring	487,148	0	For
SILVERCREST ASSET MANAGEMENT GROUP LLC	456,975	13,087	For
Boston Trust Walden Co	306,966	0	For
LONDON CO OF VIRGINIA	284,882	0	For
Aristotle Capital Boston, LLC	271,571	0	For
Fisher Asset Management, LLC	236,806	21,684	Mixed
Victory Capital	235,843	0	For
Hood River Capital Management LLC	229,159	0	For
PRINCIPAL GLOBAL INVESTORS	208,021	0	For
Fidelity	195,949	0	For
HEARTLAND ADVISORS INC	188,331	0	For

Institutional-manager reports, all 262 managers: 31,752,262 for, 825,125 against, 104,478 abstained, 1,693 not voted. Showing the 25 largest; see all in the interactive database.

11. 3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 47,738,769AGAINST: 1,049,682

Details: description as filed, official tally, votes by 113 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 29, 2025.

HAEMONETICS CORP.’s own tally for this item (“3. The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes”): 47,738,769 for, 1,049,682 against — passed, per its Form 8-K filed July 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 31,342,447 for, 28,543 against, 16,920 abstained.

FOR

FOR: 31,342,447AGAINST: 28,543ABSTAIN: 16,920

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	Mixed
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of August 4, 2023, which belongs to the 2023-2024 season; 11 items from the meeting of July 24, 2025, which belongs to the 2025-2026 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest HAEMONETICS CORP. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.

Fund voting reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	12.11%
2	Capital Group	7.20%
3	BlackRock	6.35%
4	AMCAP FUND	5.97%
5	Neuberger Berman	4.43%
6	Fidelity	2.50%
7	T. Rowe Price	2.36%
8	Royce	1.99%
9	Thrivent	1.58%
10	Dimensional	1.49%

Institutional-manager reports: top HAEMONETICS CORP. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#	Asset manager	% of shares outstanding
1	Capital Research Global Investors	13.26%
2	Neuberger Berman	7.26%
3	Wellington	6.03%
4	T. Rowe Price	4.12%
5	State Street	3.29%
6	BlackRock	3.10%
7	FRANKLIN ADVISERS INC	2.49%
8	GEODE CAPITAL MANAGEMENT, LLC	2.22%
9	Thrivent	1.59%
10	SCHRODER INVESTMENT MANAGEMENT GROUP	1.43%

Reported HAEMONETICS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

HAEMONETICS CORP. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.43%	13F
Vanguard Group	9.97%	13F
Neuberger Berman Group LLC	6.90%	DEF14A
AQR Capital Management, LLC	6.18%	13G
Vanguard Portfolio Management	5.08%	13G
Wellington Management Group LLP	4.31%	13G
T. Rowe Price Investment Management, Inc.	4.29%	13G
State Street	3.75%	13F
Geode Capital	2.39%	13F
Dimensional Fund Advisors	2.08%	13F

Percentages above are of 51,152,886 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated June 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated June 29, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At HAEMONETICS CORP.'s shareholder meeting held July 25, 2024, in the 2024-2025 proxy season, 349 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 4,862 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — HAEMONETICS CORP.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on July 25, 2024.

HAEMONETICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.